Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 12/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | FAP | Q12884 | 1/20 | 0.30 |
| ▸ | PITRM1 | Q5JRX3 | 1/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14899641 | 0.88 | DPP4 (0.36) | DPP4DPP8DPP9CYP3A4FAP | |
| SCHEMBL8270356 | 0.88 | DPP4 (0.36) | DPP4DPP8DPP9CYP3A4FAP | |
| SCHEMBL8269752 | 0.88 | DPP4 (0.36) | DPP4DPP8DPP9CYP3A4FAP | |
| SCHEMBL14532904 | 0.80 | DPP4 (0.46) | DPP4DPP8DPP9CYP3A4FAP | |
| SCHEMBL8328208 | 0.80 | DPP4 (0.46) | DPP4DPP8DPP9CYP3A4FAP | |
| SCHEMBL14899591 | 0.79 | DPP4 (0.36) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL15827635 | 0.79 | DPP4 (0.37) | DPP4DPP8DPP9CYP3A4FAP | |
| SCHEMBL12969791 | 0.77 | DPP4 (0.43) | DPP4DPP8DPP9CYP3A4 | |
| SCHEMBL8269749 | 0.76 | DPP4 (0.43) | DPP4DPP8DPP9CYP3A4FAP | |
| SCHEMBL2434106 | 0.76 | DPP4 (0.43) | DPP4DPP8DPP9CYP3A4FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2995615-A1 | CYCLOPROPYL-FUSED PYRROLIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND THEIR PHARMACEUTICAL USE | AstraZeneca AB (SE) | 2016-03-16 | — | — | EP | disclosed |